Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors

High-risk human papillomavirus (HPV) are responsible for genital and oral cancers associated with the expression of the E6/E7 HPV oncogenes. Therapeutic vaccines targeting those oncogenes can only partially control tumor progression, highlighting the necessity to investigate different treatment stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingos-Pereira, Sonia, Galliverti, Gabriele, Hanahan, Douglas, Nardelli-Haefliger, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503370/
https://www.ncbi.nlm.nih.gov/pubmed/31060612
http://dx.doi.org/10.1186/s40425-019-0593-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503370/
https://www.ncbi.nlm.nih.gov/pubmed/31060612
http://dx.doi.org/10.1186/s40425-019-0593-1

Ejemplares similares